BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Enck P, Klosterhalfen S. Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders. Front Psychiatry 2020;11:797. [PMID: 33192627 DOI: 10.3389/fpsyt.2020.00797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Brierley SM, Greenwood-Van Meerveld B, Sarnelli G, Sharkey KA, Storr M, Tack J. Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome. Nat Rev Gastroenterol Hepatol 2022. [PMID: 36168049 DOI: 10.1038/s41575-022-00682-y] [Reference Citation Analysis]
2 Xiao M, Zhong LLD, Lam WC, Zhao Y, Gwee KA, Holtmann G, Tack J, Suzuki H, Chen MH, Xiao Y, Hou X, Liu J, Li Y, Tang XD, Lu F. Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial. Trials 2022;23:454. [PMID: 35655286 DOI: 10.1186/s13063-022-06396-5] [Reference Citation Analysis]
3 Huang H, Lu L, Chen Y, Zeng Y, Xu C. The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis. Nutr J 2022;21:24. [PMID: 35509010 DOI: 10.1186/s12937-022-00777-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Weimer K, Buschhart C, Broelz EK, Enck P, Horing B. Bibliometric Properties of Placebo Literature From the JIPS Database: A Descriptive Study. Front Psychiatry 2022;13:853953. [PMID: 35401284 DOI: 10.3389/fpsyt.2022.853953] [Reference Citation Analysis]
5 Zyczynski HM, Richter HE, Sung VW, Lukacz ES, Arya LA, Rahn DD, Visco AG, Mazloomdoost D, Carper B, Gantz MG; NICHD Pelvic Floor Disorders Network. Percutaneous Tibial Nerve Stimulation vs Sham Stimulation for Fecal Incontinence in Women: NeurOmodulaTion for Accidental Bowel Leakage Randomized Clinical Trial. Am J Gastroenterol 2022;117:654-67. [PMID: 35354778 DOI: 10.14309/ajg.0000000000001605] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Jones MP, Yun G, Wass F, Rixon H, Shah A, Walker MM, Koloski NA, Holtmann G, Talley NJ, Beath AP. The role of mood state and emotion regulation in the discrepancy between gastrointestinal symptom burden recorded prospectively and via recall questionnaire. Neurogastroenterol Motil 2021;:e14304. [PMID: 34854512 DOI: 10.1111/nmo.14304] [Reference Citation Analysis]
7 Glissen Brown JR, Lembo AJ. Therapeutics, Placebo, and the Importance of Hard Outcomes in Irritable Bowel Syndrome Research. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01177-0. [PMID: 34752965 DOI: 10.1016/j.cgh.2021.10.041] [Reference Citation Analysis]
8 Simons M, Taft TH, Doerfler B, Ruddy JS, Bollipo S, Nightingale S, Siau K, van Tilburg MAL. Narrative review: Risk of eating disorders and nutritional deficiencies with dietary therapies for irritable bowel syndrome. Neurogastroenterol Motil 2021;:e14188. [PMID: 34254719 DOI: 10.1111/nmo.14188] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Enck P, Klosterhalfen S. The Placebo and Nocebo Responses in Clinical Trials in Inflammatory Bowel Diseases. Front Pharmacol 2021;12:641436. [PMID: 33867990 DOI: 10.3389/fphar.2021.641436] [Cited by in F6Publishing: 4] [Reference Citation Analysis]